Etidronate ameliorates painful soft-tissue calcification in werner syndrome

Journal of the American Geriatrics Society

Volumn 53, Issue 11, 2005, Pages 2038-2039

  Honjo, Satoshi ^a   Yokote, Koutaro ^a   Takada, Aki ^a   Maezawa, Yoshiro ^a   Kobayashi, Kazuki ^a   Tokuyama, Takahiko ^a   Sonezaki, Kiriko ^a   Saito, Yasushi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; ETIDRONIC ACID; PARATHYROID HORMONE; PHOSPHORUS; WERNER SYNDROME PROTEIN;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DNA DETERMINATION; FEMALE; HUMAN; LETTER; RADIODIAGNOSIS; SOFT TISSUE CALCIFICATION; TREATMENT OUTCOME; WERNER SYNDROME;

ADENOSINE TRIPHOSPHATASES; CALCINOSIS; CONNECTIVE TISSUE; DNA HELICASES; DNA MUTATIONAL ANALYSIS; ETIDRONIC ACID; FEMALE; FINGERS; HUMANS; MIDDLE AGED; PAIN; RECQ HELICASES; TREATMENT OUTCOME; WERNER SYNDROME;

EID: 29244488563     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.00479_5.x     Document Type: Letter

References (5)

1. Fleisch H. Bisphosphonates: Mechanisms of action. Endocr Rev 1998;19:80-100.
2. Yu CE, Oshima J, Fu YH et al. Positional cloning of the Werner's syndrome gene. Science 1996;272:258-262.
3. Fleisch H, Russell RGG, Bisaz S et al. The influence of pyrophosphate analogues (diphosphonates) on the precipitation in vitro and in vivo. Calcif Tissue 1968;2:10-10A.
4. Epstein CJ, Martin GM, Shultz AL et al. Werner's syndrome. A review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 1966;45:177-221.
5. Leone A, Costantini AM, Brigida R et al. Soft-tissue mineralization in Werner syndrome. Skeletal Radiol 2005;34:47-51.